Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes

Public Assistance-Hospitals of Marseille (AP-HM)

Status: Completed

Conditions: Acute Coronary Syndromes

Treatments: Other: blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT02117037

2014-04

Details and patient eligibility

About

This prospective study aimed to validate a new prognostic approach of endothelial progenitor cells associated biomarkers in patients with acute coronary syndromes . Recruitment is made prospectively by two centers of Inter -region South Mediterranean,

Enrollment: 180 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• acute coronary syndrome (ST + < 12 hours and ST- high risk or intermediate risk ),which there is an indication of percutaneous coronary intervention.

Exclusion criteria

• Cancer
• Chronic inflammatory disease
• Infectious disease
• Erythrocyte <4 G/l
• Thrombopénia less than 100 000/mm3 ;

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

180 participants in 1 patient group

study of PEC markers and chemokines/ chemokine recep

Other group

Description:

blood sample for dosage and study of PEC markers and chemokines/ chemokine receptors

Treatment:

Other: blood sample